期刊文献+

联用阿司匹林和替罗非班预防进行PCI术后的冠心病患者出现亚急性血栓的效果探析 被引量:1

下载PDF
导出
摘要 目的:探讨联用阿司匹林和替罗非班预防进行经皮冠状动脉介入(PCI)术后的冠心病患者出现亚急性血栓的效果。方法:选取在高邮市人民医院进行PCI术的60例冠心病患者作为研究对象。将这些患者平均分为对照组和观察组。在对这些患者进行PCI术前,为对照组患者联用阿司匹林和氯呲格雷进行治疗,为观察组患者联用阿司匹林和替罗非班进行治疗。然后比较在手术后两组患者亚急性血栓的发生率。结果:手术后,观察组患者亚急性血栓的发生率低于对照组患者(P <0.05)。结论:联用阿司匹林和替罗非班预防进行PCI术后的冠心病患者出现亚急性血栓的效果较为理想。
作者 程石
出处 《当代医药论丛》 2018年第22期145-146,共2页
  • 相关文献

二级参考文献64

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33020
  • 2Puri A, Bansal A, Narain VS, et al. Comparative assessment of platelet GpIIb/IIIa receptor occupan cy ratio with Eptifibatide/Tirofiban in patients presenting with ACS and undergoing PCI. Indian Heart J, 2013, 65(2):152.
  • 3Blancas Gomez-Casero R, Quintana Diaz M, Chana Garcia M, et al. Influence of the combination of antiplatelet agents on the occurrence of early left ventricular insufficiency in patients with acute coronary syndromes without persistent ST-segment elevation. Med Clin, 2014,142(7):293.
  • 4Rubboli A,Oldgren J,Marin F,et al. Combination of a neworal anticoagulant, aspirin and clopidogrel after acu tecoronary syndrome: new therapeutic standard. Intern EmergMed, 2013’ 8(8): 673.
  • 5Maruyama H,Fukuoka T,Deguchi I, et al. Dual antiplatelet therapy clopidogrel with low -dose cilostazol intensifies platelet inhibition in patients with ischemic stroke. Intern Med, 2013,52(10): 1043.
  • 6Nazif TM, Mehran R, Lee EA, et al. Comparative effectiveness of upstream glycoprotein Ilb/IIIa inhibitors in patients with moderate - and high —risk acute coronary syndromes: an Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) substudy. Am Heart J, 2014, 167(1): 43.
  • 7Boersma E, Harrington RA, Molitemo DJ, et aL Platelet glycoprotein Ilb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet,2002,359(9302): 189.
  • 8Boersma E, Harrington RA, Moliterno DJ, et al. platelet glycoprotein iib/iiia inhibitors in acute coronary major randomised clinical trials[J] 198 syndromes : a meta - analysis of all Lancet, 2002, 359(9302):189-.
  • 9James S, Akerblom A,Cannon CP,et al. comparison of ticagrelor, the first reversible oral p2y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: rationale, design, and baseline characteristics of the platelet inhibition and patient outcomes (plato) trial[ J]. Am Heart J, 2009, 157 (4) :599 - 605.
  • 10Tsimikas S. Drug - eluting stents and late adverse clinical outcomes lessons learned, lessons awaited [ J ]. J Am Coil Cardiol, 2006,47 (10) :2112 -2115.

共引文献76

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部